GNLX
GENELUX Corp
NASDAQ · Healthcare · Biotechnology · US
$1.96
+2.08%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.50x
- Price / sales
- —
- Price / cash flow
- -3.51x
Enterprise value
- Enterprise value
- $72.4M
- EV / sales
- 9053.86x
- EV / EBITDA
- -2.12x
- EV / EBIT
- -2.03x
- Market cap
- $88.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026